Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Trial of Neoadjuvant Sunitinib in Patients With Bulky GIST.

Next Previous
Trial Profile

Pilot Trial of Neoadjuvant Sunitinib in Patients With Bulky GIST.

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Aug 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Gastrointestinal stromal tumours
  • Focus Adverse reactions

Most Recent Events

  • 26 Apr 2016 Status changed from active, no longer recruiting to discontinued.
  • 24 Sep 2013 Planned end date changed from 1 May 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.
  • 17 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top